Benjamin Svoboda

Benjamin Svoboda has a diverse work experience in the biopharmaceutical industry, with a focus on bioassay and immunoassay analytical methods. Benjamin began their career as a Production Supervisor and Laboratory Analyst at ELISA Technologies, Inc. in 2001. Benjamin then worked as a Laboratory Technician at COBE Cardiovascular from 2003 to 2004 and as a Laboratory Analyst at Lancaster Laboratories from 2004 to 2005.

In 2005, Benjamin joined Amgen where they held various roles, including Senior Associate QC, Associate Scientist, and Specialist QC. In these positions, they were responsible for the performance, development, validation, and transfer of immunoassay and bioassay analytical methods for Quality Control (QC) under current Good Manufacturing Practices (cGMP). Benjamin also played a key role in automating these methods using the Tecan Freedom EVO platform and implementing inventory management systems.

In 2016, Benjamin worked as a Quality Consultant at The DiLisi Group, Inc., providing consulting support for Amgen, Inc. Benjamin managed projects for the creation of a global automation program and automated bioassay analytical methods using the Tecan Freedom EVO platform.

Since 2017, Benjamin has been working at KBI Biopharma. Benjamin started as a Scientist II and then progressed to roles such as Senior Scientist Group Lead and Bioassay Group Lead/Senior Scientist. These positions involve leading and managing the bioassay group, and continuing work on bioassay automation.

Overall, Benjamin Svoboda has extensive experience in bioassay and immunoassay analytical methods, automation, project management, and Quality Control in the biopharmaceutical industry.

Benjamin Svoboda holds a Bachelor of Science (BS) degree in Microbiology and Cell Science, which they completed at the University of Florida in 2003.